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Abstract
Evolutionary medicine (EM) is a growing field focusing
on the evolutionary basis of human diseases and their
changes through time. To date, the majority of EM
studies have used pure theories of hominin
macroevolution to explain the present-day state of
human health. Here, we propose a different approach
by addressing more empirical and health-oriented
research concerning past, current and future
microevolutionary changes of human structure,
functions and pathologies. Studying generation-to-
generation changes of human morphology that
occurred in historical times, and still occur in present-
day populations under the forces of evolution, helps
to explain medical conditions and warns clinicians
that their current practices may influence future
humans. Also, analyzing historic tissue specimens such
as mummies is crucial in order to address the
molecular evolution of pathogens, of the human
genome, and their coadaptations.
Keywords: anatomical variation, empirical, evolution-
ary medicine, microevolution, mortality, pathology,
secular trends
Definition, history of evolutionary medicine
research and present situation
Evolutionary medicine (EM), or Darwinian medicine as it
is sometimes called, investigates human disease vulner-
ability and disease etiologies (genetics, behavior, environ-
ment, pathogens, and so on) from an evolutionary
perspective. EM is a biomedical scientific concept of
increasing interest since the 1990s [1,2]. It has been the
topic of several textbooks [3-5] and also recently a major
scientific colloquium [6]. The intellectual beginnings of
evolutionary medicine stemmed from the recognition
that past evolutionary events can explain present-day
conditions of the human body. Thus, by applying the
concept of nature’s evolution to human morphology,
physiology and pathophysiology, a better understanding
of the etiology of present-day human ailments can be
achieved. Early applications of poorly understood Darwi-
nian concepts to human biology led to eugenic theories
[7,8]. However, EM (as we strongly emphasize here) does
not deal with eugenic approaches. It espouses approaches
to population biology that do not deal with individuals,
but with intergenerational manifestations of biological
processes that have no value attached to them.
Humans still evolve, in terms of anatomical structures
and physiological processes as well as disease patterns and
prevalence. The platonic, essentialist view that Homo
sapiens, once formed, remains the same biological entity
throughout the centuries is patently incorrect. Irrespective
of the disparate views on the origin of humans held by
adherents to different religions and scientific theories,
changes in human genes and phenotypes from generation
to generation do occur. Microevolutionary changes in
human lineages during historical times are clearly under-
standable in the evolution of immunity to diseases, but
also in the appearance of new metabolic processes such as
lactose tolerance [9] or in the widespread acquisition of
genetic variations in the capacity to process ethanol [10].
They have occurred in anatomical structures, too; such
significant changes in morphological characteristics
include: decrease in the robusticity of the musculoskeletal
apparatus (gracilization) [11,12], weight and height [13],
microcranialization and brachycephalization (reduction in
braincase size and change of its shape) [14], reductions in
the size and number of teeth [15] and spinal morphology
alterations [16]. These alterations are all likely to be at
least partially the result of structural reductions in
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response to technology diminishing the need for the use of
physical strength and introducing extraoral food proces-
sing. Aside from genetic changes, such alterations may
occur due to environmental changes such as a reduction
of chewing effort in the processing of food, leading to a
mechanically caused reduction in jaw size.
Microevolution is observable as a process of changes
occurring in phenotypes of successive generations. These
changes may result from changing, under the operation
of forces of evolution, gene frequencies, or from adaptive
phenotypic responses to changing living conditions. The
changes of gene frequencies are a part of the general evo-
lutionary process involving mating systems, drift, gene
flow, mutations and selection. They can only occur
through the process of reproduction that requires the
genetic endowment of one generation to be passed on to
the next generation. During that process frequencies of
alleles or of genotypes can be altered leading to perma-
nent alterations of immune responses, physiological pro-
cesses and anatomical structures. Phenotypic adaptive
responses are modifiable through alteration of living con-
ditions during the lifespan of one generation, but only
within the limits of genetically determined plasticity of
individual responses to environmental stimuli.
Theoretically, the minimum time span required for
microevolutionary change of the gene pool is that of two
generations, while there is no constraint on the minimum
time span for an adaptive phenotypic change. Since, due
to a long human fertile lifespan of some 30 years, genera-
tions are widely overlapping in living populations, while
living conditions in modern economies change rapidly, it
is not always easy to distinguish between a truly evolution-
ary change and a phenotypic secular trend if the specific
genetic determination of changing functions or structures
is not known. Although classic descriptions of evolution-
ary processes refer to long time spans, there is no reason
to expect that a change in gene frequencies may not occur
during the time span of a century. The average age of par-
ents at the time they produce offspring is approximately
20 to 40 years and thus on average three generations can
be turned over during a century, each providing an oppor-
tunity for change of gene frequencies. This change may be
rapid if a particular force of evolution operates strongly.
For example, gene flow resulting from mass migration
may profoundly alter the gene pool of a given geographic
region within several decades.
Human microevolution has recently accelerated due
to the rapid growth of human population numbers
facilitated through cultural development and technolo-
gies [17]. Phenotypic manifestations of these changes
are sometimes referred to as secular (derived from the
Latin term saeculum, for ‘a generation’) or microevolu-
tionary alterations. A distinction can be made between
secular changes and microevolutionary alterations,
based on their causes as explained earlier. Secular
changes, such as increases in stature or weight are
usually alterations of phenotypic expression of genetic
potential without any changes in gene frequencies,
while true microevolution involves change of gene fre-
quencies, like in the case of accumulating mutations.
Since for many morphological and physiological char-
acters the exact mode of inheritance is not known, the
distinction between phenotypic adaptive trends and
true microevolution may be made by observing
whether the magnitude of a particular change exceeds
the range of adaptive phenotypic responses of the same
genetic potential. If generation-to-generation changes
exceed full phenotypic expression of the same genetic
potential they can be considered microevolutionary
ones, since they must reflect the changing genetic
endowment of successive generations.
Most microevolutionary alterations have medical
implications for individual patients (for example, knowl-
edge of current anatomical variations for surgeons) as
well as at the population level (for example, sociospecific
public health measures). Studies of microevolutionary
changes require time depths of at least a few genera-
tions, thus EM research specifically uses historic sam-
ples, where the time periods investigated extend over a
number of centuries or even a few millennia. The value
of such studies of ancient tissues has become more and
more accepted even for clinical research, particularly as
a crucial reservoir to study the evolution of infectious
diseases [18-21].
The aim of this review is to highlight the potential of
novel directions in EM empirical research for current and
future biological and medical applications rather than dis-
cuss pure theoretical understanding of the origin of
humans. Thus, it discusses present-day public health activ-
ities and biomedical practices from a perspective of future
generations. Furthermore, the value of ancient tissue sam-
ples such as mummified bodies and archaeological bones
and teeth to study recent evolution of human disease is
addressed, as well as the possible impact of EM on aca-
demic curricula.
Current EM research
Major fields of primarily non-clinical EM research to date
have included aspects of demography [22], evolutionary
genetics [23], sex [24], and socioanthropological issues
[25]. The value of EM has been recognized particularly
for clinical research [26,27]. Presently, EM concepts have
been applied in clinical settings with a major focus on
disease-provoking morphology, for example, of the
human spine [28], on the changes in infectious diseases
through time [3], explanations of psychiatric diseases
such as depression, schizophrenia, anxiety disorders, and
personality disorders [29-31], metabolic disorders such as
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iron deficiency [32] or nutrition-based pathological
effects [33,34].
Possible approaches in future EM studies
Relaxed natural selection and microevolution of
human morphology
One major field for future evolutionary research with a
particular biomedical perspective is the study of altera-
tions of natural selection, understood as differential
reproductive success of carriers of different genes, and
its impact on human morphology and pathology.
Over the entire evolution of humankind, there was a
very significant opportunity for the process of natural
selection (Figure 1). It mostly occurred due to high levels
of differential mortality that allowed less than half of
individuals born to pass on their genes to next genera-
tions, eliminating the other half [35]. Until the mid-19th
century infant and child mortality was so high that the
survivorship to age 15 years was around 50% or some-
what less, even in countries presently considered to be
‘developed’ [36,37]. Although some deaths happened
without a link to individual genetic endowment, many
were linked to varying physical strength, levels of immu-
nity, metabolic disorders (for example, type 1 diabetes,
phenylketonuria), vision defects [38] and less common
congenital defects. Differential fertility contributed much
less to the overall opportunity for selection since there
was little genetic variation in this characteristic [39]. This
situation has changed drastically during the last approxi-
mately 150 years with the most welcome advent of
sanitation and generally available medical treatments.
The opportunity for natural selection through differential
mortality has been so severely reduced that, at the end of
the 20th century, more than 90% of newborns had an
opportunity to fully participate in the reproduction of the
next generation [36], while fertility became dependent on
the conscious decisions of individuals and couples in
both the sense of avoiding births and giving birth by
infertile couples. For the first time in the evolution of
humanity, the majority of natural selection pressures
were relaxed to the apparent benefit of all of us. The
increase in variability of heritable traits is a predictable
outcome of such a relaxation of selection as its stabilizing
effects are diminished [40]. This might not be true for
psychiatric disorders, where social pressure may still
influence reproductive success [31]. There is also evi-
dence that, at least for some disorders, psychiatric disor-
ders may be linked to allele variations that predispose to
differential susceptibility and adverse effects in terms of
developing a disorder [41]. At the genetic level, alleles do
not have an absolute adaptive or maladaptive value, they
assume it by interaction with the rest of the genome and
the epigenetics determines their Darwinian fitness [42]. A
gene producing pathological effects in the past (for exam-
ple, predisposition to type I diabetes mellitus) may not be
considered maladaptive in an environment where there is
an effective treatment for diabetes.
One can multiply such clinically relevant examples of
relaxed natural selection. For example, an increase in
the range of human biological variation has been already
Figure 1 Changes in the Biological State Index over the last 15,000 years of human evolution. The index value is a probability that an
average person will be able to fully participate in reproduction of the next generation. The lower the index value the greater the opportunity
for natural selection. Labels in the formula are: dx = a fraction of dying people of age x; sx = reproductive value of a person of age x (for
example, s65 = 0, while s15 = 1). For further explanation and data see [35,70].
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documented for a plethora of anatomical structures.
Some ‘anomalous’ arteries have more than doubled their
prevalence (for example, the median artery of the fore-
arm is now present in around 30% of individuals in dif-
ferent populations, while at the beginning of the 20th
century it was present in only around 10% of individuals
[43]) (Figure 2), and the thyroidea ima branch of the
aortic arch had disappeared completely by the end of
the 20th century [44].
Climatic factors have been proposed to influence the
altered prevalence of the internal thoracic artery [45]. In
the skeletal system, opening of the sacral canal (spina
bifida occulta) became more common in cohorts born
in the second half of the 20th century than it was before
[46], and tarsal coalitions appear more often in more
modern times, too [47]. Skeletal pathologies such as
ossification of the posterior longitudinal ligament of the
spine have increased [48] as have diffuse idiopathic ske-
letal hyperostosis [49]. Many other rather short-term
changes of body morphology, such as alterations in
body dimensions and proportions (for example, body
mass index, skeletal robustness or bone density) have
also been shown. The widely reported secular increase
in stature, which occurred with varying speeds (from 0
to over 150 mm per century [50]) in various popula-
tions, has affected body proportions since most of the
stature increase, where it occurred, was due to the
growth of the lower extremities [51].
Also, the current epidemic of obesity may in part result
from increasing variation in the size of the body frame
that reflects a greater variation in the size of the gastroin-
testinal tract [52] rather than just caloric imbalance. The
range of variations of hormones regulating human appe-
tite, for example, leptin and ghrelin and enzymes regulat-
ing carbohydrate and fat metabolism in past and present
populations may differ, thus adding to the evolutionary
explanation for part of the obesity problem. Although it
can be argued that short-term changes in body height
and body weight are not the result of changes in gene fre-
quencies, but simply adaptive, non-heritable responses to
changing living conditions, the ability of the human body
to respond to such changes is a product of its earlier evo-
lution. The response, especially in the case of increasing
body weight, seems to be harmful and needs to be treated
by interventions based on the understanding of human
heritable adaptations to past diets, the so called thrifty
genotype hypothesis debate (for example, modern dia-
betes-causing genes were advantageous in the past) [53].
The economic impact of such body shape alterations on
‘biological standards of living’ has been addressed pre-
viously [54]. Besides direct economic costs, obesity is
linked to increased mortality and morbidity and thus any
short-term alteration in obesity rates will have huge pub-
lic health implications. Finally, it is also not clear if the
entirety of body height increases that occurred during
the 20th century are adaptive rather than of a genetic
nature [55].
Regulation of postnatal growth and development has
undergone a significant transformation during the last
century. This change has become most obvious in the
adolescent period [56]. Sexual maturity accelerated, while
the rates of growth at puberty became much higher than
before, resulting in problems in adolescence [56]. It
remains to be determined to what extent acceleration of
Figure 2 Frequencies of individuals with median arteries of forearms by date of birth in a sample of 284 South African dissection
cadavers. Trend of increase in the incidence is significant (c2(1) = 11.90, P <0.001 z = 3.94, P <0.0011 (z test for linear trends in proportions)). For
further data see [71].
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sexual maturation and increases in peak growth velocity
are the result of alterations in socioeconomic conditions,
and to what extent microevolution of human growth reg-
ulation has occurred. Studies of the occurrence of skele-
tal manifestations such as hyperostosis frontalis interna,
may possibly further elucidate the recent evolution of the
human endocrine system [57].
Other examples might be the alterations in prevalence
and the etiology of metabolic syndrome, and the intro-
duction of biologically active substances (for example,
xenoestrogens or endocrine disruptors) into the food
chain [58]. Finally, even within short time periods disor-
ders of unknown cause, such as Paget’s disease, can show
a notable yet etiologically enigmatic alteration in preva-
lence [59]. Thus, recording these secular alterations is
the very first step to explore possible environmental
cofactors of such disorders. It is evident that our biologi-
cal properties are changing even within very short histor-
ical time frames. More research elucidating what changes
occur, with what intensity and to predict their biomedical
consequences is needed, and should be a major future
field of EM research.
Lessons from paleopathology: Evolution of diseases and
genomic studies
Of special importance to EM is the subdiscipline of paleo-
pathology, which attempts to describe diseases in the past
and to trace changes of those diseases in response to the
historical development of humans, especially during the
last several thousand years. From diagnoses of individual
cases observed in ancient skeletons and in mummies, the
discipline has evolved into palaeoepidemiological studies
[60,61], even though meta-analytic standards known from
clinical studies can hardly ever be met. Studies have dis-
cussed the impact of recent genetic sweeps such as the
positive selection of Tay-Sachs disease-affected people
versus tuberculosis [62]. Also, sex differences in genetic
vulnerability to cancer or arteriosclerosis can be addressed
by EM research.
Many attempts at explaining host-pathogen coevolu-
tion in relation to major infectious diseases such as
leishmaniasis or plague have been made [63,64].
Epigenetics is another field for future EM research.
Epigenetic factors mediating gene expression such as
early-in-life stress (’fetal programming’) would be one
such example. Poor intrauterine conditions are predictive
for somatic and psychiatric disorders, including maternal
adversity [65]. Since it has been suggested that micro-
RNA is linked with human pathologies such as cancer,
molecular evolutionary studies may solve certain etiologi-
cal enigmas. Another example, the lively and still conti-
nuing debate about the origin of syphilis [66,67], has
stimulated closer scrutiny of pathogens, the study of their
impact on the health of populations, systems of public
health and ways of handling the recent resurgence of
treatment resistant forms of the disease. For genomic
studies in particular, new technological advances will
allow more sensitive and specified research.
Outlook
Medically oriented empirical research with an evolution-
ary focus may help to redesign public health policies and
public awareness of science. A ‘morphological anomaly’
may become more frequent or even ‘normal’ in a given
population and, thus, it should be no reason for concern
for a particular individual. This needs to be realized and
communicated accordingly (for example, by general prac-
titioners to their patients). Accepting variation as normal
is an important issue in clinical medicine.
To summarize, human biological traits still evolve. We
are not simply ‘stone age bodies in a modern world’, but
we are both at the same time adapted and adapting; biolo-
gical compromises in a rapidly changing environment,
with the latter also being full of coevolving pathogens.
Therefore, future clinical studies in EM should focus parti-
cularly on the genomic evolution of bacterial and viral dis-
eases and responses in the evolution of human immune
system. For the latter, DNA viruses are easier to extract
than RNA viruses. Issues such as viral pandemics or evolu-
tion of strain-dependent virulence can be explored by
using a temporal and thus historical perspective. As high-
lighted previously [68], the imminent conflict of our short-
term and long-term evolutionary genetic endowment is
etiologically linked to the major causes of death in first-
world countries such as cardiovascular or oncological dis-
ease. Thus, any progress in fighting disease based on evo-
lutionary insights would be most welcome in the medical
community, as well as in the general community. With the
prospect of improved ancient DNA and proteomic ana-
lyses, we are now only at the edge of an entirely new era
that will allow us to unravel the mysteries of human dis-
ease evolution. Furthermore, the incorporation of princi-
ples of human evolution and its forces into the knowledge
of future medical practitioners is needed. A general practi-
tioner may not directly heal a patient using only EM prin-
ciples, but without any evolutionary knowledge he/she
certainly will not be able to provide the best, individualized
diagnosis, medicosocial advice and prescribe optimal per-
sonal treatment [69]. The same is true for any biomedical
researcher; not applying EM principles may restrict the
true scientific impact and applicability of a particular
research result. Thus, the introduction of EM topics into
medical (and science) curricula is recommended.
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